Visum Pharmaceutical

Company Deals

Visum Pharma Series B+ Financing to Advance R&D and GMP Workshop Construction

Fineline Cube Jun 30, 2022

Visum Pharmaceutical Co., Ltd reportedly raised close to RMB 100 million (USD 14.9 million) in...

Company Drug

Merus’ Bizengri Becomes First FDA-Approved Therapy for NRG1 Fusion-Positive Cholangiocarcinoma

Company Drug

Zai Lab Secures FDA Fast Track Designation for DLL3-Targeting ADC Zocilurtatug Pelitecan in Extrapulmonary NEC

Company Deals

Mindray Bio-Medical Re-Files for Hong Kong Listing After Initial Application Expiration

Company Drug

Ribo Life Science Files EMA Application for Vortosiran Phase IIb Study in Venous Thromboembolism Prevention